|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pawa N, Arulampalam T and Norton JD:
Screening for colorectal cancer: established and emerging
modalities. Nat Rev Gastroenterol Hepatol. 8:711–722. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di Lena M, Travaglio E and Altomare DF:
New strategies for colorectal cancer screening. World J
Gastroenterol. 19:1855–1860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahlquist DA and Shuber AP: Stool screening
for colorectal cancer: evolution from occult blood to molecular
markers. Clin Chim Acta. 315:157–168. 2002. View Article : Google Scholar
|
|
5
|
van Turenhout ST, Oort FA, Terhaar sive
Droste JS, et al: Hemorrhoids detected at colonoscopy: an
infrequent cause of false-positive fecal immunochemical test
results. Gastrointest Endosc. 76:136–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Rossum LG, van Rijn AF, Laheij RJ, et
al: Random comparison of guaiac and immunochemical fecal occult
blood tests for colorectal cancer in a screening population.
Gastroenterology. 135:82–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Velez JP, Schwesinger WH, Stauffer J, et
al: Bidirectional endoscopy in patients with fecal occult blood.
Surg Endosc. 16:117–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo X, Stock C, Burwinkel B and Brenner H:
Identification and evaluation of plasma microRNAs for early
detection of colorectal cancer. PLoS One. 8:e628802013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carmona FJ, Azuara D, Berenguer-Llergo A,
et al: DNA methylation biomarkers for noninvasive diagnosis of
colorectal cancer. Cancer Prev Res (Phila). 6:656–665. 2013.
View Article : Google Scholar
|
|
10
|
Calistri D, Rengucci C, Bocchini R, et al:
Fecal multiple molecular tests to detect colorectal cancer in
stool. Clin Gastroenterol Hepatol. 1:377–383. 2003. View Article : Google Scholar
|
|
11
|
Leung WK, To KF, Man EP, et al: Detection
of epigenetic changes in fecal DNA as a molecular screening test
for colorectal cancer: a feasibility study. Clin Chem.
50:2179–2182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong SM, Traverso G, Johnson C, et al:
Detecting colorectal cancer in stool with the use of multiple
genetic targets. J Natl Cancer Inst. 93:858–865. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leung WK, To KF, Man EP, et al: Detection
of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal
samples of patients with colorectal cancer or polyps. Am J
Gastroenterol. 102:1070–1076. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalimutho M, Del Vecchio Blanco G,
Cretella M, et al: A simplified, non-invasive fecal-based DNA
integrity assay and iFOBT for colorectal cancer detection. Int J
Colorectal Dis. 26:583–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Loganayagam A: Faecal screening of
colorectal cancer. Int J Clin Pract. 62:454–459. 2008. View Article : Google Scholar
|
|
16
|
Ahlquist DA: Molecular detection of
colorectal neoplasia. Gastroenterology. 138:2127–2139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boynton KA, Summerhayes IC, Ahlquist DA
and Shuber AP: DNA integrity as a potential marker for stool-based
detection of colorectal cancer. Clin Chem. 49:1058–1065. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalimutho M, del Blanco GV, Gravina P, et
al: Quantitative denaturing high performance liquid chromatography
(Q-dHPLC) detection of APC long DNA in faeces from patients with
colorectal cancer. Clin Chem Lab Med. 48:1303–1311. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calistri D, Rengucci C, Molinari C, et al:
Quantitative fluorescence determination of long-fragment DNA in
stool as a marker for the early detection of colorectal cancer.
Cell Oncol. 31:11–17. 2009.
|
|
20
|
Bedi A, Pasricha PJ, Akhtar AJ, et al:
Inhibition of apoptosis during development of colorectal cancer.
Cancer Res. 55:1811–1816. 1995.PubMed/NCBI
|
|
21
|
Arends MJ, Morris RG and Wyllie AH:
Apoptosis. The role of the endonuclease. Am J Pathol. 136:593–608.
1990.PubMed/NCBI
|
|
22
|
Japanese Society for Cancer of the Colon
and Rectum. Japanese Classification of Colorectal Carcinoma. 8th
edition. Kanehara & Co., Ltd; Tokyo: pp. 172013
|
|
23
|
Tsujitani S, Shirai H, Tatebe S, et al:
Apoptotic cell death and its relationship to carcinogenesis in
colorectal carcinoma. Cancer. 77(Suppl 8): 1711–1716. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahlquist DA, Harrington JJ, Burgart LJ and
Roche PC: Morphometric analysis of the “mucocellular layer”
overlying colorectal cancer and normal mucosa: relevance to
exfoliation and stool screening. Human Pathol. 31:51–57. 2000.
View Article : Google Scholar
|
|
25
|
Sträter J, Wedding U, Barth TF, Koretz K,
Elsing C and Möller P: Rapid onset of apoptosis in vitro follows
disruption of beta 1-integrin/matrix interactions in human colonic
crypt cells. Gastroenterology. 110:1776–1784. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peitsch MC, Mannherz HG and Tschopp J: The
apoptosis endonucleases: cleaning up after cell death? Trends Cell
Biol. 4:37–41. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Caldarella A, Crocetti E, Messerini L and
Paci E: Trends in colorectal incidence by anatomic subsite from
1985 to 2005: a population-based study. Int J Colorectal Dis.
28:637–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou H, Harrington JJ, Klatt KK and
Ahlquist DA: A sensitive method to quantify human long DNA in
stool: relevance to colorectal cancer screening. Cancer Epidemiol
Biomarkers Prev. 15:1115–1119. 2006. View Article : Google Scholar : PubMed/NCBI
|
